News

ZYMOX® Receives Notable Recognition for Pet Healthcare Products

ZYMOX® Receives Notable Recognition for Pet Healthcare Products

ZYMOX® Products Shine in Editor's Select Awards

The acclaimed enzymatic pet healthcare brand, ZYMOX, has recently achieved remarkable acclaim by receiving top honors in four categories: Bird, Dog, Reptile, and Small Animal. This recognition emphasizes the brand's unwavering commitment to enhancing pet well-being through its innovative products.

A Legacy of Quality and Innovation

Pet King Brands, the founder of ZYMOX, has a longstanding reputation for excellence in creating veterinarian-recommended enzymatic products. The company has consistently introduced groundbreaking solutions that cater to the health needs of pets worldwide. The recent acknowledgment by Pet Age magazine speaks volumes about the company's dedication to providing high-quality pet care solutions.

Highlighted Products

Among the honored products are the ZYMOX Avian Care line, featuring both the ZYMOX Avian Care Topical Solution and the ZYMOX Avian Care Topical Spray, specifically designed for birds. Other celebrated offerings include ZYMOX Enzymatic Ear Solution with 0.5% Hydrocortisone and the ZYLAFEN® Topical Solution. Additionally, the ZYMOX Small Animal & Exotic line showcases exceptional products like the ZYMOX Small Animal & Exotic Topical Solution and the ZYMOX Small Animal & Exotic Topical Spray.

Commitment to Pet Health

Debra Decker, Director of Marketing at Pet King Brands, shared her enthusiasm regarding the recognition: "We're honored to have six of our ZYMOX products recognized in four of the Editor's Select categories. The LP3 Enzyme System – combined with our dedication to manufacturing each ZYMOX product in the USA – truly sets our offerings apart. This acknowledgment from Pet Age's 2026 Editor's Select Awards reinforces the exceptional science and care behind everything we create."

Importance of the Editor's Select Program

The Editor's Select program by Pet Age aims to recognize products that exemplify high standards in quality and effectiveness for improving pet health. The selection process identifies innovations that are poised to enhance the well-being of pets, ensuring that only the best products make it to the final list.

Explore More

The complete list of honorees for the Pet Age "2026 Editor's Select" program is available online, showcasing an impressive lineup of recognized pet care products. For those interested in learning more about ZYMOX and its offerings, detailed product information can be found on the official website.

Contact Information and About Pet King Brands

For media inquiries or more information about ZYMOX products, please contact K. Sutherland PR at (775) 360-6101. Pet King Brands has been a leader in enzyme-based, veterinarian-approved pet healthcare since 1998. The company, led by President and Founder Pamela Bosco, prides itself on its innovative LP3 Enzyme System that revolutionizes care for animals' ears, skin, and dental health.

Frequently Asked Questions

What is ZYMOX recognized for by Pet Age?

ZYMOX was awarded for its high-quality products in four specific categories—Bird, Dog, Reptile, and Small Animal.

What types of products does ZYMOX offer?

ZYMOX offers a variety of products including ear solutions, topical care solutions, and dental care products specifically designed for pets.

Who leads Pet King Brands?

Pet King Brands is led by Pamela Bosco, who is the President and Founder of the company.

How does the LP3 Enzyme System benefit pets?

The LP3 Enzyme System works gently to clean and maintain the health of pets' ears, skin, and mouths, minimizing the need for harsh chemicals.

Where can I find more information about ZYMOX?

More information about ZYMOX products can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 228

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 34

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 121

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 74

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Fluor Corporation's Recent Class Action Developments

Updated Category News Views 255

Fluor Corporation: An Overview of Recent Developments Fluor Corporation is a global leader in providing engineering, procurement, and construction (EPC) services, along with project management support. The company is dedicated to delivering essential infrastructure and the latest technology solutions while enhancing its operational efficiencies. Class Period and...

Continue Reading
Securing Your Rights: A Call to Sarepta Therapeutics Investors

Updated Category News Views 150

Urgent Reminder for Sarepta Therapeutics Investors In light of recent legal developments, it's crucial for investors of Sarepta Therapeutics, Inc. to take action regarding their investments in this biopharmaceutical company. Investors who acquired securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) are being notified of upcoming legal deadlines that could impact their...

Continue Reading
GMT Pay Revolutionizes Everyday Spending with Web3 Earnings

Updated Category News Views 151

GMT Pay: A New Era in Payment Solutions Welcome to the exciting world of GMT Pay, the groundbreaking payment solution that allows users to turn their Web3 earnings into everyday purchases. This innovative platform is spearheaded by FSL, the development studio behind the renowned Web3 lifestyle app, STEPN. With GMT Pay, users can easily access their earnings from various...

Continue Reading
Trucept, Inc. Unveils 2022 Financial Results and Future Prospects

Updated Category News Views 40

Trucept, Inc. Announces Major Financial Developments Trucept Inc. DBA Afinida is excited to share its audited financial results for the year 2022. With a keen focus on delivering transparency, the company underscores its commitment to its shareholders and clients alike. CEO Norman Tipton expresses optimism about the upcoming 2023 financial report, which is expected to be...

Continue Reading
Bitcoin's Critical Support Level for Future Growth Explained

Updated Category News Views 174

Understanding Bitcoin's Correction Phase Bitcoin's (CRYPTO: BTC) ongoing correction phase has garnered much attention among traders and investors alike. Key Insights From Technical Analysis Technical analyst Kevin has pointed out that Bitcoin's correction patterns notably exhibit similarities across different market cycles. Historically, even amidst various macroeconomic...

Continue Reading